176 related articles for article (PubMed ID: 21338244)
21. Comparative metabolic profiles of total and partial body radiation exposure in mice using an untargeted metabolomics approach.
Maan K; Tyagi R; Dutta A; Bakhshi R; Rana P
Metabolomics; 2020 Nov; 16(12):124. PubMed ID: 33245511
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers of furan exposure by metabolic profiling of rat urine with liquid chromatography-tandem mass spectrometry and principal component analysis.
Kellert M; Wagner S; Lutz U; Lutz WK
Chem Res Toxicol; 2008 Mar; 21(3):761-8. PubMed ID: 18269250
[TBL] [Abstract][Full Text] [Related]
23. Fecal and urinary NMR-based metabolomics unveil an aging signature in mice.
Calvani R; Brasili E; Praticò G; Capuani G; Tomassini A; Marini F; Sciubba F; Finamore A; Roselli M; Marzetti E; Miccheli A
Exp Gerontol; 2014 Jan; 49():5-11. PubMed ID: 24184118
[TBL] [Abstract][Full Text] [Related]
24. Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes.
Connor SC; Hansen MK; Corner A; Smith RF; Ryan TE
Mol Biosyst; 2010 May; 6(5):909-21. PubMed ID: 20567778
[TBL] [Abstract][Full Text] [Related]
25. Effects of menstrual cycle phase on metabolomic profiles in premenopausal women.
Wallace M; Hashim YZ; Wingfield M; Culliton M; McAuliffe F; Gibney MJ; Brennan L
Hum Reprod; 2010 Apr; 25(4):949-56. PubMed ID: 20150174
[TBL] [Abstract][Full Text] [Related]
26. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins.
Beckwith-Hall BM; Nicholson JK; Nicholls AW; Foxall PJ; Lindon JC; Connor SC; Abdi M; Connelly J; Holmes E
Chem Res Toxicol; 1998 Apr; 11(4):260-72. PubMed ID: 9548796
[TBL] [Abstract][Full Text] [Related]
27. An integrative chemometric approach and correlative metabolite networking of LC-MS and
Maan K; Baghel R; Bakhshi R; Dhariwal S; Tyagi R; Rana P
Mol Omics; 2022 Mar; 18(3):214-225. PubMed ID: 34982087
[TBL] [Abstract][Full Text] [Related]
28. Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study.
Shariff MI; Gomaa AI; Cox IJ; Patel M; Williams HR; Crossey MM; Thillainayagam AV; Thomas HC; Waked I; Khan SA; Taylor-Robinson SD
J Proteome Res; 2011 Apr; 10(4):1828-36. PubMed ID: 21275434
[TBL] [Abstract][Full Text] [Related]
29. Urine metabolomics analysis for adrenal incidentaloma activity detection and biomarker discovery.
Kotłowska A; Sworczak K; Stepnowski P
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(5-6):359-63. PubMed ID: 21247813
[TBL] [Abstract][Full Text] [Related]
30. Monitoring diet effects via biofluids and their implications for metabolomics studies.
Gu H; Chen H; Pan Z; Jackson AU; Talaty N; Xi B; Kissinger C; Duda C; Mann D; Raftery D; Cooks RG
Anal Chem; 2007 Jan; 79(1):89-97. PubMed ID: 17194125
[TBL] [Abstract][Full Text] [Related]
31. Benzo(a)pyrene-induced metabolic responses in Manila clam Ruditapes philippinarum by proton nuclear magnetic resonance ((1)H NMR) based metabolomics.
Zhang L; Liu X; You L; Zhou D; Wang Q; Li F; Cong M; Li L; Zhao J; Liu D; Yu J; Wu H
Environ Toxicol Pharmacol; 2011 Sep; 32(2):218-25. PubMed ID: 21843802
[TBL] [Abstract][Full Text] [Related]
32. The metabolic fate of red wine and grape juice polyphenols in humans assessed by metabolomics.
van Dorsten FA; Grün CH; van Velzen EJ; Jacobs DM; Draijer R; van Duynhoven JP
Mol Nutr Food Res; 2010 Jul; 54(7):897-908. PubMed ID: 20013882
[TBL] [Abstract][Full Text] [Related]
33. NMR metabolic analysis of samples using fuzzy K-means clustering.
Cuperlović-Culf M; Belacel N; Culf AS; Chute IC; Ouellette RJ; Burton IW; Karakach TK; Walter JA
Magn Reson Chem; 2009 Dec; 47 Suppl 1():S96-104. PubMed ID: 19731396
[TBL] [Abstract][Full Text] [Related]
34. Metabolomic biomarkers in a model of asthma exacerbation: urine nuclear magnetic resonance.
Saude EJ; Obiefuna IP; Somorjai RL; Ajamian F; Skappak C; Ahmad T; Dolenko BK; Sykes BD; Moqbel R; Adamko DJ
Am J Respir Crit Care Med; 2009 Jan; 179(1):25-34. PubMed ID: 18931331
[TBL] [Abstract][Full Text] [Related]
35. Statistical significance analysis of nuclear magnetic resonance-based metabonomics data.
Goodpaster AM; Romick-Rosendale LE; Kennedy MA
Anal Biochem; 2010 Jun; 401(1):134-43. PubMed ID: 20159006
[TBL] [Abstract][Full Text] [Related]
36. (1)H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool.
Zira AN; Theocharis SE; Mitropoulos D; Migdalis V; Mikros E
J Proteome Res; 2010 Aug; 9(8):4038-44. PubMed ID: 20527959
[TBL] [Abstract][Full Text] [Related]
37. Probing gender-specific metabolism differences in humans by nuclear magnetic resonance-based metabonomics.
Kochhar S; Jacobs DM; Ramadan Z; Berruex F; Fuerholz A; Fay LB
Anal Biochem; 2006 May; 352(2):274-81. PubMed ID: 16600169
[TBL] [Abstract][Full Text] [Related]
38. Toxicometabolomics of urinary biomarkers for human gastric cancer in a mouse model.
Kim KB; Yang JY; Kwack SJ; Park KL; Kim HS; Ryu DH; Kim YJ; Hwang GS; Lee BM
J Toxicol Environ Health A; 2010; 73(21-22):1420-30. PubMed ID: 20954069
[TBL] [Abstract][Full Text] [Related]
39. [Metabonomic profile of urine from rats administrated with different treatment period of rifampin].
Liao Y; Peng SQ; Yan XZ; Chen HB; Zhang LS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Dec; 30(6):696-702. PubMed ID: 19180919
[TBL] [Abstract][Full Text] [Related]
40. Metabolomic analysis of biofluids from rats treated with Aconitum alkaloids using nuclear magnetic resonance and gas chromatography/time-of-flight mass spectrometry.
Sun B; Li L; Wu S; Zhang Q; Li H; Chen H; Li F; Dong F; Yan X
Anal Biochem; 2009 Dec; 395(2):125-33. PubMed ID: 19683504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
